Fierce Pharma September 30, 2024
Sponsored By Phreesia

Patients with rare or complex diseases often struggle to find specialists who meet their specific condition and individual needs. But care delays can negatively impact health outcomes, especially in diseases that are progressive in nature, including multiple sclerosis (MS) and other autoimmune disorders, cancer and many rare conditions.

The solution? Meet patients in more impactful ways during their doctor search.

It’s crucial to connect patients with relevant information on symptoms and conditions when they are most in need of answers – before they receive a diagnosis. Doing so can help get someone to the right doctor to make a diagnosis and keep them on the path to effective treatment, explain Katherine Perez, VP Global Patient Advocacy and Policy, and Susan...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
J&J drops 340B rebate plan following government pressure
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
Metabolic Meds Biotech Kailera Launches With $400M for Next-Generation Weight-Loss Drugs
What's Next for Pharmacy Teams? Executives Weigh In
The top biopharma conferences in 2025

Share This Article